← Back to All Filings

ResMed Director Files Intent to Sell $504K in Stock

Low SignificanceNovember 12, 2025 at 5:33:02 PM EST

RESMED INC

$RMD144CIK: 0000943819

Subscribe to track RMD

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

ResMed Director Files Intent to Sell $504K in Stock

Company: RESMED INC (RMD) Form: 144 | Filed: 2025-11-12 Significance: Low

Insider: Peter C Farrell Title: Director | Relationship: Director

Transaction: • Type: Proposed Sale • Shares: 2,000 • Value: $504,100 • Price: ~$252.05 • Owned After: Not Stated

Key Insight: A director has filed a notice of proposed sale for a small amount of stock, representing a negligible fraction (<0.002%) of the company's market cap. The sale is pre-scheduled under a 10b5-1 plan.

Market Context: ResMed is a large-cap company with a market capitalization of over $36 billion. This transaction is considered routine and immaterial.

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: RESMED INC (RMD)

Executive Summary

  • Trading Significance: Low
  • Key Takeaway: A director has filed a notice for a small, pre-planned sale of stock that is immaterial to the company's market capitalization.
  • Market Impact: Negligible. The transaction is too small to influence market sentiment or trading volume.

Company Information

FieldValue
CompanyRESMED INC
Ticker SymbolRMD (Note: Not listed in filing)
CIK0000943819
IndustrySurgical & Medical Instruments & Apparatus

Insider Information

FieldValue
NamePeter C Farrell
CIK0001186102
Title/PositionDirector
RelationshipDirector

Transaction Details

FieldValue
Form Type144 (Notice of Proposed Sale)
Transaction Date2025-11-12 (Approximate)
Transaction CodeN/A
Security TypeCommon Stock
Shares Involved2,000
Price Per Share~$252.05 (Calculated)
Total Value$504,100
Shares Owned AfterNot Stated
Ownership TypeNot Stated

Financial Impact Assessment

Transaction Materiality

MetricValue
Transaction Value$504,100
% of Market Cap0.0014%
Shares Transacted2,000
% of Shares Outstanding0.0014%
Materiality AssessmentLow

Impact Evaluation

  • Market Cap Context: The $504,100 transaction is insignificant for a company with a market capitalization of $36.51 billion.
  • Transaction Significance: The sale represents a negligible fraction of both the company's market value and its total shares outstanding, indicating a routine portfolio adjustment by the insider rather than a strategic move.

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral
  • Reasoning: The transaction is extremely small relative to the company's size and was pre-scheduled under a 10b5-1 plan, removing any speculative element.

Volume & Sentiment

  • Expected Volume Impact: None. The number of shares is too small to affect trading volume.
  • Sentiment Indicator: Neutral. This filing is unlikely to influence investor sentiment.

Additional Context

Special Circumstances

  • The filing indicates a trading plan was adopted on August 12, 2025, suggesting this is a pre-scheduled transaction under a Rule 10b5-1 plan.
Topics:#SECFiling#InsiderTrading#ResMed#RMD#Form144#InsiderSell#StockMarket#Investing

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.